Vaccines & Disease · Tetanus

Tetanus Vaccine & Disease Information

Below are brief introductions to tetanus disease and the tetanus vaccine with links to more information. Scroll down for a list of QUICK FACTS that provide a summary overview of key facts for the disease and the vaccine.

The Disease

Tetanus: The Disease

Tetanus (lockjaw) disease is caused by Clostridium tetani (C. tetani), an anaerobic, gram-positive bacterium that can form spores. Tetanus spores can be found in soil, manure, and the digestive tracts of animals and humans. Additionally, tetanus bacteria have reportedly been found in contaminated heroin and on skin surfaces.1 Tetanus bacteria do not survive in the presence of oxygen; however, they are quite resistant to most chemicals and even heat.2 Puncture wounds, which do not bleed very much and are protected by tissue and skin from direct exposure to oxygen, can be the perfect environment for tetanus bacteria to multiply and cause infection.3

The incubation period for tetanus infection, from exposure to the appearance of the initial symptoms, ranges from three days to three weeks.4 Initial symptoms include muscular stiffness of the jaw and neck, headache, seizures, changes in heart rate and blood pressure, fever, and chills. Complications include fractures, vocal cord spasms, impaired breathing, pulmonary embolism, pneumonia, infections acquired in the hospital during treatment, and death.5

The Vaccine

Tetanus Vaccine

In the U.S. today, tetanus vaccine is available in combination with other vaccines. There are 10 different tetanus-containing vaccines available for use in the U.S. with differing use rules based on age groups. The U.S. Centers for Disease Control and Prevention (CDC) currently recommends children receive 5 doses of tetanus-containing vaccines between two months of age and 12 years of age and a dose every ten years thereafter throughout adulthood.6 In an effort to reduce pertussis rates in infants, the CDC also recommends a dose of the tetanus-containing vaccine Tdap during each pregnancy, regardless of a previous history of Tdap vaccine.7

Quick Facts

Tetanus at a glance

Tetanus Quick Facts

  1. Since the early 1900s, reported tetanus deaths dramatically declined prior to the introduction of vaccines in the late 1940s. Factors contributing to the decline include improvements in wound care, use of tetanus immune globulin (TIG), and decreases in exposure due to population movement from rural to urban environments.8
  2. Tetanus is not contagious and cannot be transmitted from person to person.9 Tetanus bacteria can enter the body when a person sustains a deep cut, or even a burn.10 Rarely, it can also occur following abortions, elective surgeries, ear infections, pregnancy, dental infections, animal bites, and crush wounds.11

Tetanus Vaccine Quick Facts

  1. According to the CDC, common tetanus vaccine reactions include redness, pain, and swelling at the injection site. However, if the pain and swelling are significant and extend from the shoulder to the elbow, the CDC warns that additional tetanus toxoid vaccination should not be more frequent than every 10 years.12 Additional serious reported side effects following tetanus toxoid vaccination include anaphylaxis,1314 brachial neuritis,15 Guillain-Barré syndrome (GBS),1617 acute disseminated encephalomyelitis (ADEM),18 arthritis,1920 and myocarditis.21
  2. The CDC reports that a single dose of tetanus toxoid will likely not protect a person from developing tetanus but that three tetanus toxoid vaccine doses should induce vaccine-acquired blood antibody levels considered to be protective against tetanus disease in nearly all individuals. Vaccine-acquired tetanus blood antibody levels, however, decrease with time and within 10 years, most individuals may only have blood antibody levels considered minimally protective against tetanus disease. Testing of antibodies in the blood can demonstrate the presence of an immune response to a particular pathogen such as tetanus, but it does not determine the level of protection that a person might have or how long protection might last.22

IMPORTANT NOTE: NVIC encourages you to become fully informed about Tetanus and the Tetanus vaccine by reading all sections in the Table of Contents, which contain many links and resources such as the manufacturer product information inserts, and to speak with one or more trusted health care professionals before making a vaccination decision for yourself or your child. This information is for educational purposes only and is not intended as medical advice.

References
  1. 1Communication and Education Branch, National Center for Immunization and Respiratory Diseases (NCIRD) and the Centers for Disease Control (CDC). Tetanus. Centers for Disease Control (CDC). Oct. 19, 2022.
  2. 2Communication and Education Branch, National Center for Immunization and Respiratory Diseases (NCIRD) and the Centers for Disease Control (CDC). Tetanus. Centers for Disease Control (CDC). Oct. 19, 2022.
  3. 3Communication and Education Branch, National Center for Immunization and Respiratory Diseases (NCIRD) and the Centers for Disease Control (CDC). Tetanus. Centers for Disease Control (CDC). Oct. 19, 2022.
  4. 4Communication and Education Branch, National Center for Immunization and Respiratory Diseases (NCIRD) and the Centers for Disease Control (CDC). Tetanus. Centers for Disease Control (CDC). Oct. 19, 2023.
  5. 5US Centers for Disease Control and Prevention. Symptoms and Complications. Aug. 29, 2022.
  6. 6Havers FP, Moro PL, Hunter P, et al. Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccines: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2019. MMWR. Jan. 24, 2020; 69:77–83.
  7. 7Liang JL, Tiwari T, Moro P, et al. Prevention of Pertussis, Tetanus, and Diphtheria with Vaccines in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. Apr. 27, 2018; 67(2):1–44.
  8. 8US Centers for Disease Control and Prevention. Chapter 16: Tetanus – Background. Feb. 6, 2020.
  9. 9Communication and Education Branch, National Center for Immunization and Respiratory Diseases (NCIRD) and the Centers for Disease Control (CDC). Tetanus. Centers for Disease Control (CDC). Oct. 19, 2022.
  10. 10MedlinePlus, US National Library of Medicine. Tetanus. Nov. 25, 2020.
  11. 11Communication and Education Branch, National Center for Immunization and Respiratory Diseases (NCIRD) and the Centers for Disease Control (CDC). Tetanus. Centers for Disease Control (CDC). Oct. 19, 2022.
  12. 12Communication and Education Branch, National Center for Immunization and Respiratory Diseases (NCIRD) and the Centers for Disease Control (CDC). Tetanus. Centers for Disease Control (CDC). Oct. 19, 2022.
  13. 13Mayorga C, Torres MJ, Corzo JL, et al. Immediate allergy to tetanus toxoid vaccine: determination of immunoglobulin E and immunoglobulin G antibodies to allergenic proteins. Ann Allergy Asthma Immunol. Feb. 2003; 90(2):238-43.
  14. 14Martín-Muñoz MF, Pereira MJ, Posadas S, et al. Anaphylactic reaction to diphtheria-tetanus vaccine in a child: specific IgE/IgG determinations and cross-reactivity studies. Vaccine 2002.
  15. 15Hamati-Haddad A, Fenichel GM. Brachial neuritis following routine childhood immunization for diphtheria, tetanus, and pertussis (DTP): report of two cases and review of the literature. Pediatrics. Apr. 1997; 99(4):602-3.
  16. 16Bakshi R, Graves MC. Guillain-Barré syndrome after combined tetanus-diphtheria toxoid vaccination. J Neurol Sci.. Apr. 15, 1997; 147(2):201-2.
  17. 17Newton N Jr, Janati A. Guillain-Barré syndrome after vaccination with purified tetanus toxoid. South Med J.. Aug. 1987; 80(8):1053-4.
  18. 18Hamidon BB, Raymond AA. Acute disseminated encephalomyelitis (ADEM) presenting with seizures secondary to anti-tetanus toxin vaccination. Med J Malaysia. Dec. 2003; 58(5):780-2.
  19. 19Jawad AS, Scott DG. Immunisation triggering rheumatoid arthritis? Ann Rheum Dis. Feb. 1989.
  20. 20Kaul A, Adler M, Alokaily F. Recurrence of reactive arthritis after a booster dose of tetanus toxoid. Ann Rheum Dis. Feb. 2002.
  21. 21Amsel SG, Hanukoglu A, Fried D. Myocarditis after triple immunisation. Arch Dis Child. Apr. 1986; 61(4): 403–405.
  22. 22MedlinePlus, US National Library of Medicine. Antibody Serology Tests. Apr. 5, 2024.
Select disease / vaccine